NervGen Pharma Corp. (NGEN)
1.78
+0.02
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
NervGen Pharma Price : 1.78 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 1.78 | 1.90 | 1.74 | 1.78 | 409597.0 |
| Oct 01, 2026 | 1.92 | 1.92 | 1.730 | 1.76 | 1.051M |
| Sep 30, 2026 | 1.91 | 1.98 | 1.90 | 1.91 | 548694.0 |
| Sep 29, 2026 | 1.86 | 1.96 | 1.84 | 1.92 | 560132.0 |
| Sep 28, 2026 | 1.89 | 1.99 | 1.88 | 1.88 | 525401.0 |
| Sep 25, 2026 | 2.00 | 2.01 | 1.915 | 1.94 | 343204.0 |
| Sep 24, 2026 | 1.98 | 2.02 | 1.91 | 2.02 | 317136.0 |
| Sep 23, 2026 | 2.05 | 2.093 | 1.955 | 1.96 | 536653.0 |
| Sep 22, 2026 | 2.00 | 2.10 | 1.99 | 2.065 | 223722.0 |
| Sep 21, 2026 | 2.06 | 2.06 | 1.96 | 1.99 | 473668.0 |
| Sep 18, 2026 | 2.27 | 2.27 | 2.04 | 2.05 | 608535.0 |
| Sep 17, 2026 | 2.15 | 2.33 | 2.09 | 2.27 | 1.159M |
| Sep 16, 2026 | 2.16 | 2.18 | 2.08 | 2.13 | 452933.0 |
| Sep 15, 2026 | 2.19 | 2.19 | 2.11 | 2.14 | 322996.0 |
| Sep 14, 2026 | 2.18 | 2.25 | 2.175 | 2.195 | 238408.0 |
| Sep 11, 2026 | 2.17 | 2.23 | 2.14 | 2.185 | 559124.0 |
| Sep 10, 2026 | 2.10 | 2.165 | 2.07 | 2.16 | 313867.0 |
| Sep 09, 2026 | 2.19 | 2.27 | 2.115 | 2.13 | 366095.0 |
| Sep 08, 2026 | 2.32 | 2.345 | 2.16 | 2.19 | 713758.0 |
| Sep 04, 2026 | 2.31 | 2.395 | 2.275 | 2.33 | 920546.0 |
| Sep 03, 2026 | 2.34 | 2.36 | 2.275 | 2.32 | 434342.0 |
| Sep 02, 2026 | 2.32 | 2.36 | 2.31 | 2.33 | 383487.0 |
| Sep 01, 2026 | 2.21 | 2.37 | 2.100 | 2.32 | 1.058M |
| Aug 31, 2026 | 2.27 | 2.30 | 2.13 | 2.21 | 798260.0 |
| Aug 28, 2026 | 2.34 | 2.40 | 2.245 | 2.28 | 869261.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| InMed Pharmaceuticals, Inc. | 1.33 |
| Milestone Pharmaceuticals, Inc. | 0.8097 |
| Clearmind Medicine, Inc. | 0.715 |
| Lexaria Bioscience Corp. | 2.88 |
| Target Group, Inc. (Canada) | 0.0007 |
Price Related Metrics
| PEG Ratio | -0.0345 |
| Price to Book Value | 15.55 |
| Earnings Yield | -30.11% |
| Market Cap | 189.41M |
| PEGY Ratio | -0.0345 |